Trial Outcomes & Findings for Feasibility of a New Ambulatory Multi-vital Signs Monitor (NCT NCT05562011)
NCT ID: NCT05562011
Last Updated: 2023-12-20
Results Overview
Number of participants who had the presence of (data existing for at least 70% of 5-minute time periods) for all of the vital signs of interest together--heart rate (HR), blood pressure (BP), respiratory rate (RR), arterial oxygen saturation (SaO2) after placement of the device on the subject's wrist and hand.
TERMINATED
NA
61 participants
Baseline
2023-12-20
Participant Flow
Participant milestones
| Measure |
Caretaker Device
participants will undergo active CarTaker monitoring for 24-48 hours
|
|---|---|
|
Overall Study
STARTED
|
61
|
|
Overall Study
COMPLETED
|
39
|
|
Overall Study
NOT COMPLETED
|
22
|
Reasons for withdrawal
| Measure |
Caretaker Device
participants will undergo active CarTaker monitoring for 24-48 hours
|
|---|---|
|
Overall Study
Withdrawal by Subject
|
3
|
|
Overall Study
Lost to Follow-up
|
1
|
|
Overall Study
Could not co-enroll with other research study--device could not be placed postop
|
1
|
|
Overall Study
Device not placed postop due to patient being discharged home after surgery (not staying overnight)
|
4
|
|
Overall Study
Device malfunction
|
13
|
Baseline Characteristics
Feasibility of a New Ambulatory Multi-vital Signs Monitor
Baseline characteristics by cohort
| Measure |
Caretaker Device Placement
n=61 Participants
Caretaker Device placement: placement of the Caretaker device at preanesthesia visit and again postoperatively
|
|---|---|
|
Age, Continuous
|
62.1 years
STANDARD_DEVIATION 14.1 • n=5 Participants
|
|
Sex: Female, Male
Female
|
39 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
22 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
3 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
23 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
31 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
2 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
2 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
61 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: BaselineNumber of participants who had the presence of (data existing for at least 70% of 5-minute time periods) for all of the vital signs of interest together--heart rate (HR), blood pressure (BP), respiratory rate (RR), arterial oxygen saturation (SaO2) after placement of the device on the subject's wrist and hand.
Outcome measures
| Measure |
Caretaker Device
n=39 Participants
participants will undergo active CareTaker monitoring for 24-48 hours
|
|---|---|
|
Preoperative Caretaker Monitor Placement Success
|
39 Participants
|
PRIMARY outcome
Timeframe: Pre-Op Hour 24Participants' description of ease of use (interfered with Activities of Daily Living (ADLs) or sleep) in Yes/No format. Data will be collected to demonstrate percent of patients who answered "Yes" to Sleep or ADL interference. Free text will also be recorded for qualitative purposes. Shows Caretaker Feasibility.
Outcome measures
| Measure |
Caretaker Device
n=39 Participants
participants will undergo active CareTaker monitoring for 24-48 hours
|
|---|---|
|
Ease of Use Determined by Number of Participants With Sleep or Activities of Daily Living (ADLs) Interference
|
16 Participants
|
PRIMARY outcome
Timeframe: Post-Op Hour 24Population: Data not collected
Using postoperative nurse verbal feedback on usability of the Caretaker monitor on subjects scheduled for surgery during the perioperative period. Percent of nurses who answer yes to the question: Did you have any difficulty using the Caretaker monitor?
Outcome measures
Outcome data not reported
PRIMARY outcome
Timeframe: Pre-Op Hour 24Population: data not collected
Number of participants with no missing values expressed
Outcome measures
Outcome data not reported
PRIMARY outcome
Timeframe: Intraoperative; from the time the Operating Room monitors are placed on the patient until they come off at the end of the case, an average of 2 hoursNumber of participants with no missing values expressed
Outcome measures
| Measure |
Caretaker Device
n=39 Participants
participants will undergo active CareTaker monitoring for 24-48 hours
|
|---|---|
|
Caretaker Data Capture Rate
|
39 Participants
|
PRIMARY outcome
Timeframe: Post-Op Hour 24Population: data not collected
Number of participants with no missing values expressed
Outcome measures
Outcome data not reported
PRIMARY outcome
Timeframe: Baseline through Pre-Op Hour 24Percent of monitors returned to our research technicians
Outcome measures
| Measure |
Caretaker Device
n=61 Participants
participants will undergo active CareTaker monitoring for 24-48 hours
|
|---|---|
|
Monitor Return Rate
|
61 Participants
|
SECONDARY outcome
Timeframe: Pre-Op hour 24, Post-Op Hour 24Outcome measures
| Measure |
Caretaker Device
n=39 Participants
participants will undergo active CareTaker monitoring for 24-48 hours
|
|---|---|
|
Heart Rate
Pre-Op Hour 24
|
94 beats per minute
Standard Deviation 19
|
|
Heart Rate
Post-Op Hour 24
|
87 beats per minute
Standard Deviation 15
|
SECONDARY outcome
Timeframe: Pre-Op Hour 24, Post-Op Hour 24Percentage of time heart rate is \<60 bpm or \>90 bpm
Outcome measures
| Measure |
Caretaker Device
n=39 Participants
participants will undergo active CareTaker monitoring for 24-48 hours
|
|---|---|
|
Heart Rate--percent of Time Parameters
Pre-Op Hour 24
|
55 percentage of time
Standard Deviation 3
|
|
Heart Rate--percent of Time Parameters
Post-Op Hour 24
|
40 percentage of time
Standard Deviation 4
|
SECONDARY outcome
Timeframe: Pre-Op hour 24, Post-Op Hour 24Outcome measures
| Measure |
Caretaker Device
n=39 Participants
participants will undergo active CareTaker monitoring for 24-48 hours
|
|---|---|
|
Respiratory Rate
Pre-Op Hour 24
|
17 respirations per minute
Standard Deviation 4
|
|
Respiratory Rate
Post-Op Hour 24
|
17 respirations per minute
Standard Deviation 4
|
SECONDARY outcome
Timeframe: Pre-Op hour 24, Post-Op Hour 24Percent of time respirations are \<8 rpm or \>20 rpm
Outcome measures
| Measure |
Caretaker Device
n=39 Participants
participants will undergo active CareTaker monitoring for 24-48 hours
|
|---|---|
|
Respiratory Rate--Percent of Time Parameters
Pre-Op Hour 24
|
21.6 percentage of time
Standard Deviation 3.8
|
|
Respiratory Rate--Percent of Time Parameters
Post-Op Hour 24
|
15.9 percentage of time
Standard Deviation 3.5
|
SECONDARY outcome
Timeframe: Post-Op Hour 24Population: data not collected
oxygen saturation level as detected by the pulse oximeter
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: Pre-Op Hour 24, Post-Op Hour 24Population: data not collected for either time point
Percentage of time SaO2 is between 95-100%
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: Pre-Op Hour 24, Post-Op Hour 24Outcome measures
| Measure |
Caretaker Device
n=39 Participants
participants will undergo active CareTaker monitoring for 24-48 hours
|
|---|---|
|
Non-Invasive Systolic Blood Pressure (SBP)
Pre-Op Hour 24
|
119 units of millimeters of mercury (mmHg)
Standard Deviation 22
|
|
Non-Invasive Systolic Blood Pressure (SBP)
Post-Op Hour 24
|
134 units of millimeters of mercury (mmHg)
Standard Deviation 24
|
SECONDARY outcome
Timeframe: Pre-Op Hour 24, Post-Op Hour 24Outcome measures
| Measure |
Caretaker Device
n=39 Participants
participants will undergo active CareTaker monitoring for 24-48 hours
|
|---|---|
|
Non-Invasive Mean Arterial Blood Pressure (MBP)
Pre-Op Hour 24
|
82 mm of Hg
Standard Deviation 18
|
|
Non-Invasive Mean Arterial Blood Pressure (MBP)
Post-Op Hour 24
|
97 mm of Hg
Standard Deviation 21
|
SECONDARY outcome
Timeframe: Pre-Op Hour 24, Post-Op Hour 24Outcome measures
| Measure |
Caretaker Device
n=39 Participants
participants will undergo active CareTaker monitoring for 24-48 hours
|
|---|---|
|
Non-Invasive Diastolic Blood Pressure (DBP)
Post-Op Hour 24
|
68 mm of Hg
Standard Deviation 16
|
|
Non-Invasive Diastolic Blood Pressure (DBP)
Pre-Op Hour 24
|
58 mm of Hg
Standard Deviation 16
|
SECONDARY outcome
Timeframe: Pre-Op Hour 24, Post-Op Hour 24Percent time MBP is \<60 mmHg and/or \>90 mmHg
Outcome measures
| Measure |
Caretaker Device
n=39 Participants
participants will undergo active CareTaker monitoring for 24-48 hours
|
|---|---|
|
Non-Invasive Blood Pressure--MBP Percent of Time Parameters
Pre-Op Hour 24
|
37 percentage of time
Standard Deviation 4
|
|
Non-Invasive Blood Pressure--MBP Percent of Time Parameters
Post-Op Hour 24
|
67 percentage of time
Standard Deviation 1
|
SECONDARY outcome
Timeframe: Day 30Percent declared dead
Outcome measures
| Measure |
Caretaker Device
n=61 Participants
participants will undergo active CareTaker monitoring for 24-48 hours
|
|---|---|
|
Mortality Rate
|
0 Participants
|
SECONDARY outcome
Timeframe: Up to Postoperative Day 30Number of days from hospital admission to discharge
Outcome measures
| Measure |
Caretaker Device
n=39 Participants
participants will undergo active CareTaker monitoring for 24-48 hours
|
|---|---|
|
Average Length of Hospital Stay
|
3.5 number of days
Standard Deviation 4.3
|
SECONDARY outcome
Timeframe: Up to Postoperative Day 30Percent of study participants transferred to an ICU during their hospital stay
Outcome measures
| Measure |
Caretaker Device
n=39 Participants
participants will undergo active CareTaker monitoring for 24-48 hours
|
|---|---|
|
ICU Transfer Rate
|
10 Participants
|
SECONDARY outcome
Timeframe: During hospitalization up to Postoperative Day 30Number of calls made to the hospital's "Rapid Response Team" (RRT) during subjects' hospital stay. The RRT is called by nurses if the patient is experiencing stroke-like symptoms, chest pain refractory to medical treatment, or vital signs (HR, RR, BP, SaO2) meeting a pre-defined out of range value.
Outcome measures
| Measure |
Caretaker Device
n=39 Participants
participants will undergo active CareTaker monitoring for 24-48 hours
|
|---|---|
|
Number of Rapid Response Team Calls
|
2 calls
|
Adverse Events
Caretaker Device
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Timothy Harwood, M.D.
Wake Forest University School of Medicine
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place